Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Calquence, acalabrutinib, Leukemia, Lymphocytic, Chronic, B-Cell, Date of authorisation: 05/11/2020, Revision: 5, Status: Authorised
TO: